We investigated the role of galectin 9 (Gal 9) in maturation of dendritic cells (DC). Culture of immature DCs with exogenous Gal 9 markedly increased the surface expression of CD40, CD54, CD80, CD83, CD86, and HLA DR in a concentration-dependent manner, although Gal 9 had no eŠect on diŠerentiation of human monocytes into immature DCs. Gal 9 treated DCs secreted IL 12 but not IL 10, and they elicited the production of Th1 cytokines (IFN g and IL 2）, but not that of the Th2 cytokines (IL 4 and IL 5) by allogeneic CD4 ＋ T cells. These eŠects of Gal 9 on immature DCs were not essentially dependent on its lectin properties, given that they were only slightly inhibited by lactose. We further found that a Gal 9 mutant that lacks b galactoside binding activity reproduced the above activities, and that an anti-Gal 9 mAb suppressed them. Gal 9 induced phosphorylation of the p38 MAPK and ERK1/2 in DCs, and an inhibitor of p38 signaling, but not inhibitors of signaling by either ERK1/2 or phosphatidylinositol 3 kinase, blocked Gal 9 induced up-regulation of costimulatory molecule expression and IL 12 production. Theseˆndings suggest that Gal 9 plays a role not only in innate immunity but also in acquired immunity by inducing DC maturation and promoting Th1 immune responses. や，ガレクチン 9 は乳癌や悪性黒色腫の転移抑制作
Immature DCs were cultured for 2 days with Gal 9 (10 mg/ml), LPS (500 ng/ml), or PBS in the presence of 20 mM lactose or 20 mM sucrose, after which the cells were analyzed for the surface expression of the indicated molecules by ‰ow cytometry. Data are representative of three independent experiments.
Cell surface marker MFI PBS Gal 9 (10 mg/ml) Gal 9 (R65D) (10 mg/ml) Immature DCs were incubated for 2 days with Gal 9 (10 mg/ml), the Gal 9(R65D) mutant (10 or 30 mg/ml), LPS (500 ng/ml), or PBS, after which the cells were analyzed for surface expression of the indicated proteins by ‰ow cytometry. Data are representative of four independent experiments. 
